STAAR Surgical (NASDAQ:STAA - Get Free Report)'s share price reached a new 52-week low on Friday . The stock traded as low as $24.71 and last traded at $24.83, with a volume of 49325 shares. The stock had previously closed at $25.39.
Analyst Ratings Changes
A number of research analysts recently issued reports on STAA shares. Stephens upgraded shares of STAAR Surgical to a "hold" rating in a report on Monday, December 2nd. Stifel Nicolaus decreased their price target on shares of STAAR Surgical from $50.00 to $44.00 and set a "buy" rating for the company in a report on Monday, August 26th. Needham & Company LLC reaffirmed a "hold" rating on shares of STAAR Surgical in a research note on Thursday, October 31st. Finally, Canaccord Genuity Group decreased their target price on STAAR Surgical from $31.00 to $28.00 and set a "hold" rating for the company in a research note on Monday, December 9th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, STAAR Surgical currently has a consensus rating of "Hold" and a consensus price target of $42.83.
Check Out Our Latest Report on STAAR Surgical
STAAR Surgical Trading Down 2.1 %
The stock's 50 day moving average is $28.91 and its two-hundred day moving average is $34.97. The stock has a market capitalization of $1.23 billion, a price-to-earnings ratio of 56.50 and a beta of 0.59.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of STAA. Arcadia Investment Management Corp MI acquired a new position in STAAR Surgical during the 3rd quarter worth approximately $37,000. Quarry LP bought a new stake in shares of STAAR Surgical in the third quarter worth $50,000. Quest Partners LLC bought a new stake in shares of STAAR Surgical in the third quarter worth $128,000. Canada Pension Plan Investment Board acquired a new position in STAAR Surgical during the second quarter worth $129,000. Finally, Van ECK Associates Corp grew its position in STAAR Surgical by 12.7% in the third quarter. Van ECK Associates Corp now owns 3,478 shares of the medical instruments supplier's stock valued at $129,000 after purchasing an additional 393 shares in the last quarter. 96.70% of the stock is currently owned by institutional investors.
About STAAR Surgical
(
Get Free Report)
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
Read More
Before you consider STAAR Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STAAR Surgical wasn't on the list.
While STAAR Surgical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
